July 7, 2020 / 11:27 AM / a month ago

BRIEF-Corvus Pharmaceuticals Initiates Clinical Trial Of Novel Immunotherapy For Patients With Covid-19

July 7 (Reuters) - Corvus Pharmaceuticals Inc:

* CORVUS PHARMACEUTICALS INITIATES CLINICAL TRIAL OF NOVEL IMMUNOTHERAPY FOR PATIENTS WITH COVID-19

* CORVUS PHARMACEUTICALS INC - REMAIN ON TRACK TO PROVIDE DATA UPDATES ON CPI-006 FOR CANCER AND CPI-818 AT MEDICAL MEETINGS LATER THIS YEAR

* CORVUS PHARMA - APPROACH STIMULATES IMMUNE RESPONSE BY ACTIVATING B CELLS TO ENHANCE ANTIBODY PRODUCTION

* CORVUS PHARMA - STUDY DESIGNED TO EVALUATE ANTI-VIRAL ANTIBODY RESPONSE IN UP TO 30 COVID-19 PATIENTS WITH MILD TO MODERATE SYMPTOMS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below